SYAB.DE
SYNLAB AG [SYAB.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SYAB.DE Stock Summary
Top 10 Correlated ETFs
SYAB.DE
Top 10 Correlated Stocks
SYAB.DE
In the News
SYAB.DE Financial details
Company Rating
-
Market Cap
2.38B
Income
92.27M
Revenue
2.64B
Book val./share
-
Cash/share
-
Dividend
0.33
Dividend %
2.81%
Employees
23.54K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
20.02
Forward P/E
-
PEG
-5.34
P/S
0.96
P/B
1.07
P/C
-
P/FCF
18.69
Quick Ratio
1.21
Current Ratio
1.45
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.43
EPS next Y
-
EPS next Q
-
EPS this Y
-38.24%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
6.69%
Revenue Q/Q
4.56%
EPS Q/Q
-159.32%
-
-
-
-
SMA20
-6.22%
SMA50
-11.11%
SMA100
-3.3%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
8%
ROC
0.05%
Gross Margin
76%
Oper. Margin
7%
Profit Margin
5%
Payout
2%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.02-12.43
52W High
-12.5%
52W Low
+31.25%
RSI
43.58
Rel Volume
-
Avg Volume
31.11K
Volume
57
Perf Week
1.16%
Perf Month
-10.26%
Perf Quarter
4.9%
Perf Half Y
3.96%
-
-
-
-
Beta
0.896
-
-
Volatility
0.25%, 0.4%
Prev Close
0.57%
Price
10.5
Change
-1.5%
SYAB.DE Financial Performance
SYAB.DE Frequently Asked Questions
What is SYNLAB AG stock symbol ?
SYNLAB AG is a DE stock and trading under the symbol SYAB.DE
What is SYNLAB AG stock quote today ?
SYNLAB AG stock price is $10.5 today.
Is SYNLAB AG stock public?
Yes, SYNLAB AG is a publicly traded company.
Company Profile
- Volume Average 31.11K
- Market Capitalization 2.38B
- Employee 23.54K
- CEO Mr. Mathieu Floreani
- Headquarters Munich,DE
- IPO Date 2021-04-30
-
Website
https://www.synlab.com 
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
